back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-02 22:08 Tx date 2025-06-27 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$11,750
+23,980 vol $0.49 each |
95,273 | |
| Filed 2024-10-08 09:22 Tx date 2024-09-30 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$11,749
+19,583 vol $0.60 each |
71,293 | |
| Filed 2023-06-25 23:16 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$11,750
+18,077 vol $0.65 each |
51,710 | |
| Filed 2022-05-19 22:01 Tx date 2022-05-18 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+12,113 vol |
19,793 | |
| Filed 2022-05-17 12:57 Tx date 2022-05-13 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+16,096 vol |
33,633 | |
| Filed 2022-04-03 21:21 Tx date 2022-03-29 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-44,368 vol |
117,658 | |
| Filed 2021-12-28 11:40 Tx date 2021-12-22 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+17,537 vol |
17,537 | |
| Filed 2021-12-28 11:38 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-22 11:30 Tx date 2021-12-21 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-44,368 vol |
275,103 | |
| Filed 2021-08-26 15:31 Tx date 2021-08-16 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-10,623.7472
-8,812 vol $1.21 each |
162,026 | |
| Filed 2021-08-17 08:35 Tx date 2021-08-17 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-8,812 vol |
319,471 | |
| Filed 2021-05-21 12:14 Tx date 2021-05-20 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+7,680 vol |
7,680 | |
| Filed 2020-08-21 21:36 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+10,000 vol $0.60 each |
170,838 | |
| Filed 2020-06-17 15:52 Tx date 2020-06-17 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-16,608 vol |
160,838 | |
| Filed 2020-06-16 16:06 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-16,608 vol |
328,283 | |
| Filed 2020-05-14 13:58 Tx date 2020-05-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
344,891 | |
| Filed 2019-08-19 15:30 Tx date 2019-08-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
337,891 | |
| Filed 2019-05-25 14:49 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
177,446 | |
| Filed 2019-05-24 12:09 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
||
| Filed 2019-05-24 12:09 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
London, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
177,446 |